TRIAL RESCUE MANAGEMENT SERVICES
BioBoston CRO provides clinical trial rescue services for sponsors that need to stabilize a delayed, underperforming, disrupted, or at-risk study and establish a credible path to the next decision. Support can include rapid current-state assessment, critical-risk containment, recovery governance, vendor and workstream coordination, timeline and budget scenarios, quality remediation, data and document recovery, transition, or focused intervention.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Identify the true causes and constraints across startup, sites, enrollment, treatment, monitoring, data, safety, supply, vendors, quality, reporting, and decisions.
Separate recoverable performance issues from structural scope, contract, capability, resource, system, responsibility, or governance problems.
Create evidence-based scenarios with risks, actions, timing, cost, quality, data, vendor, and decision implications.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Confirm the purpose, current state, intended use, milestone, stakeholders, responsibilities, systems or vendors, and agreed deliverables.
2. Review available source materials, prior decisions, procedures, evidence, and open issues; issue a focused gap and dependency list.
3. Develop the work plan, specifications, document, assessment, or control package included in scope.
4. Coordinate review through named sponsor and cross-functional decision owners and maintain a controlled open-item and comment process.
5. Perform the agreed technical, quality, consistency, or operational checks and document remaining risks or limitations.
6. Prepare the approved handoff, implementation, submission, remediation, archive, or next-step package as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Develop the detailed integrated schedule, critical path, scenarios, milestone readiness, and timeline recovery controls.
Manage vendor recovery, evidence, deliverables, metrics, issues, escalation, transition, and acceptance.
Reconcile financial exposure, change orders, scenarios, forecast, and cost to complete during recovery.
Investigate and remediate specific quality failures, findings, recurring deviations, or control weaknesses affecting recovery.
Expertise
Trial-rescue leadership should match the study phase, product, operational model, countries and sites, vendor landscape, failure modes, data and safety state, quality risks, financial exposure, and transition complexity.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
A planned checklist for participants, sites, enrollment, monitoring, data, safety, supply, vendors, quality, TMF, timeline, budget, governance, and decisions.
A planned framework for recover, transition, redesign, pause, or stop scenarios and their evidence, risk, timing, cost, and triggers.
A planned checklist for contracts, responsibilities, data, documents, systems, access, open work, quality, finance, knowledge, sites, and continuity.
FAQs
Scope may include rapid assessment, containment, root-cause and dependency analysis, recovery scenarios, governance, timeline and budget reset, vendor improvement or transition, quality remediation, data and TMF recovery, and implementation oversight.
Timing depends on urgency, access, confidentiality, records, systems, vendors, stakeholders, and resource availability. A compressed diagnostic should still define scope, evidence, decision owners, and immediate risk controls.
BioBoston can support assessment, transition planning, vendor selection interfaces, knowledge and record transfer, continuity, and sponsor-side governance. The exact operational delivery model and replacement vendor responsibilities must be defined.
Yes. A focused work package may address timeline, data, vendor, budget, TMF, quality, CAPA, responsibility, or governance when the interfaces and broader risks are understood.
Timeline management focuses on schedule logic and recovery. Trial rescue addresses the connected
operating system of the study, including vendors, sites, data, safety, quality, supply, budget, records,
governance, and strategic options.
No. The assessment may conclude that recovery, transition, redesign, pause, or termination is most supportable. Outcomes depend on the study condition, evidence, vendors, sites, participants, data, safety, resources, authorities, and sponsor decisions.
PROJECT FORM
Share the study, missed milestones, enrollment and site status, vendors, data and safety state, quality issues, budget exposure, prior recovery actions, and the decision leadership must make. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the study condition, participants, sites, vendors, data, safety, quality, supply, timeline, budget, prior actions, and executive decision. BioBoston can then define the rapid diagnostic and phased recovery or transition scope.
